Is Newamsterdam Pharma Co Nv Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: NAMS) stock is to Buy NAMS stock.
Out of 1 analyst, 0 (0%) are recommending NAMS as a Strong Buy, 1 (100%) are recommending NAMS as a Buy, 0 (0%) are recommending NAMS as a Hold, 0 (0%) are recommending NAMS as a Sell, and 0 (0%) are recommending NAMS as a Strong Sell.
According to 1 Wall Street analyst that have issued a 1 year NAMS price target, the average NAMS price target is $22.00, with the highest NAMS stock price forecast at $22.00 and the lowest NAMS stock price forecast at $22.00.
The Wall Street analyst predicted that Newamsterdam Pharma Co Nv's share price could reach $22.00 by Apr 3, 2024. The average Newamsterdam Pharma Co Nv stock price prediction forecasts a potential upside of 141.23% from the current NAMS share price of $9.12.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.